Criminal Code Regulations 2019

Criminal Code Regulations 2019 made under the Criminal Code Act 1995 Compilation No. 6 Compilation date: 13 December 2025 Includes amendments: F2025L01544 About this compilation This compilation This is a compilation of the Criminal Code Regulations 2019 that shows the text of the law as amended and in force on 13 December 2025 (the compilation date ). The notes at the end of this compilation (the endnotes ) include information about amending laws and the amendment history of provisions of the compiled law. Uncommenced amendments The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). Application, saving and transitional provisions If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes. Editorial changes For more information about any editorial changes made in this compilation, see the endnotes. Presentational changes The Legislation Act 2003 provides for First Parliamentary Counsel to make presentational changes to a compilation. Presentational changes are applied to give a more consistent look and feel to legislation published on the Register, and enable the user to more easily navigate those documents. Modifications If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register. Self ‑ repealing provisions If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes. Contents Part 1—Preliminary 1 Name 3 Authority 4 Definitions Part 2—The security of the Commonwealth Division 1—Control orders 5 Legal representation for young people 6 Court may request legal aid commission to arrange representation 7 AFP to inform relevant persons of request and contact details Division 2—Preventative detention orders 8 Corresponding State preventative detention laws Division 3—Continuing detention orders 9 Terrorist offender unable to engage legal representative in continuing detention order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control 10 Sharing information—prescribed persons Part 3—Dangers to the community Division 1—Serious drugs and precursors 11 Controlled drugs 12 Controlled plants 13 Controlled precursors 14 Border controlled drugs 15 Border controlled plants 16 Border controlled precursors Division 2—Psychoactive substances 17 Importing psychoactive substances 18 Importing substances represented to be serious drug alternatives 19 Conditions for importing certain substances Division 3—Cross ‑ border firearms trafficking 20 Firearm law Division 4—Community safety orders 20A Serious offender unable to engage legal representative in community safety order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control 20B Sharing information—prescribed persons Part 4—National infrastructure 21 Dangerous or harmful substances and things that must not be carried by post Part 5—Application, saving and transitional provisions Division 1—Provisions for this instrument as originally made 22 Things done under the Criminal Code Regulations 2002 23 Conduct, event, circumstances occurring before commencement Schedule 1—Controlled drugs 1 Controlled drugs and quantities Schedule 2—Border controlled drugs 1 Border controlled drugs and quantities Endnotes Endnote 1—About the endnotes Endnote 2—Abbreviation key Endnote 3—Legislation history Endnote 4—Amendment history Part 1 — Preliminary 1 Name This instrument is the Criminal Code Regulations 2019 . 3 Authority This instrument is made under the Criminal Code Act 1995 . 4 Definitions In this instrument: AFP member has the same meaning as in Part 5.3 of the Code. authorised person means a person who is an authorised person for the purposes of regulation 5 of the Customs (Prohibited Imports) Regulations 1956 . chief executive officer of a legal aid commission of a State or Territory means the person holding, or performing the duties of, the following position: (a) for New South Wales, Victoria, Queensland and the Australian Capital Territory—Chief Executive Officer of the legal aid commission of that State or Territory; (b) for Western Australia—Director of Legal Aid under the Legal Aid Commission Act 1976 (WA); (c) for South Australia—Director of Legal Services under the Legal Services Commission Act 1977 (SA); (d) for Tasmania—Director of the Commission under the Legal Aid Commission Act 1990 (Tas.); (e) for the Northern Territory—Director of Legal Aid under the Legal Aid Act 1990 (NT). Code means the Criminal Code . control order has the same meaning as in Part 5.3 of the Code. Health Secretary means the Secretary of the Department administered by the Minister administering the Therapeutic Goods Act 1989 . issuing court has the same meaning as in Part 5.3 of the Code. lawyer has the same meaning as in Part 5.3 of the Code. legal aid commission means an authority established by or under a law of a State or Territory for the purpose of providing legal assistance. young person means a person who is at least 14 but under 18. Part 2 — The security of the Commonwealth Division 1 — Control orders 5 Legal representation for young people For the purposes of subsection 104.28(6) of the Code, this Division provides in relation to the appointing of a lawyer to act for a young person in relation to proceedings relating to a control order. 6 Court may request legal aid commission to arrange representation An issuing court may request a legal aid commission to arrange the legal representation of a young person in proceedings relating to a control order. 7 AFP to inform relevant persons of request and contact details (1) This section applies if an issuing court requests a legal aid commission under section 6 to arrange the legal representation of a young person in proceedings relating to a control order. Informing the legal aid commission (2) An AFP member, or a legal representative of the Australian Federal Police, must: (a) in writing, inform the chief executive officer of the legal aid commission of the request; and (b) give the legal aid commission the following information that the AFP member or legal representative has: (i) the young person’s name; (ii) the young person’s residential address; (iii) the young person’s contact details, including a telephone number and an email address; (iv) the young person’s date of birth; (v) the name, residential address and contact details of at least one parent or guardian of the young person; (vi) if the young person requires assistance with communication—information about the assistance required. Note: For subparagraph (b)(vi), a young person may need assistance with communication because, for example, the person is deaf or hearing impaired, is unable to read, has a mental impairment, or requires an interpreter. Informing the young person (3) An AFP member, or a legal representative of the Australian Federal Police, must: (a) inform the young person of the request; and (b) give the young person sufficient information about the legal aid commission to enable the young person to contact and, if necessary, attend the legal aid commission, including the following information that the AFP member or legal representative has: (i) the name of the legal aid commission; (ii) the legal aid commission’s business address (not being a post box); (iii) the legal aid commission’s contact details, including a telephone number and an email address; (iv) any other information about the legal aid commission provided by the issuing court; and (c) ensure that the young person understands the information provided to them under paragraphs (a) and (b) (taking into account the person’s age, language skills, mental capacity and any other relevant factor). (4) Subsection (3) does not apply if the actions of the young person make it impracticable for the AFP member or legal representative to comply with that subsection. Informing a parent or guardian of the young person (5) An AFP member, or a legal representative of the Australian Federal Police, must take reasonable steps to: (a) inform at least one parent or guardian of the young person of the request; and (b) give the parent or guardian the information about the legal aid commission that is required to be provided to the young person under paragraph (3)(b). Timing (6) An AFP member or legal representative of the Australian Federal Police complying with subsection (2), (3) or (5) must do so as soon as practicable after the issuing court makes the request and at least 48 hours before the next day when the court will conduct proceedings relating to the control order. Division 2 — Preventative detention orders 8 Corresponding State preventative detention laws For the purposes of the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, the following are declared to correspond to Division 105 of the Code: (a) Part 2A of the Terrorism (Police Powers) Act 2002 (NSW); (b) Part 2A of the Terrorism (Community Protection) Act 2003 (Vic.); (c) the Terrorism (Preventative Detention) Act 2005 (Qld); (d) the Terrorism (Preventative Detention) Act 2006 (WA); (e) the Terrorism (Preventative Detention) Act 2005 (SA); (f) the Terrorism (Preventative Detention) Act 2005 (Tas.); (g) Part 2 of the Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT); (h) Part 2B of the Terrorism (Emergency Powers) Act 2003 (NT). Division 3 — Continuing detention orders 9 Terrorist offender unable to engage legal representative in continuing detention order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control For the purposes of paragraph 105A.15A(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond an offender’s control in relation to a continuing detention order proceeding: (a) the offender’s financial circumstances; (b) whether the offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding; (c) whether the offender has made any efforts to obtain legal aid or legal assistance, and the outcomes of any such efforts; (d) any other matter that the Court considers relevant. 10 Sharing information—prescribed persons For the purposes of subsections 105A.19(1) and (3) of the Code, the following persons are prescribed: (a) an AFP employee (within the meaning of the Australian Federal Police Act 1979 ); (b) a member of the police force or police service of a State or Territory; (c) an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole; (d) a person who provides services for, or on behalf of: (i) a State or Territory; or (ii) an authority of a State or Territory; in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole; (da) a person who provides services for, or on behalf of, the Commonwealth in relation to a person (the service recipient ) if: (i) a post ‑ sentence order or an interim post ‑ sentence order is in force in relation to the service recipient; or (ii) the AFP Minister has made, or is considering making, an application for a post ‑ sentence order or an interim post ‑ sentence order in relation to the service recipient; (e) the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory; (f) a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983 ) or of a similar body established under a law of a State or Territory; (g) the Director ‑ General of Security, a Deputy Director ‑ General of Security, an ASIO employee (within the meaning of the Australian Security Intelligence Organisation Act 1979 ) or an ASIO affiliate (within the meaning of that Act); (h) an APS employee of a Department administered by the Minister administering: (i) the Migration Act 1958 ; or (ii) the Australian Citizenship Act 2007 ; or (iii) the Australian Passports Act 2005 ; (i) a person: (i) who is an authorised officer (within the meaning of Division 9A of Part IB of the Crimes Act 1914 ); or (ii) who, under a delegation from such an authorised officer, exercises powers or performs functions of the authorised officer under Division 9A of Part IB of the Crimes Act 1914 ; (j) a person who is a relevant expert and who is: (i) appointed by the AFP Minister under section 105A.18D of the Code; or (ii) otherwise engaged, by the AFP Minister, or a person on behalf of the AFP Minister; to assess the risk of a terrorist offender committing a serious Part 5.3 or 5.3A offence (all within the meaning of Division 105A of the Code) for the purposes of that Division (whether or not an application for a post ‑ sentence order has been made). Part 3 — Dangers to the community Division 1 — Serious drugs and precursors 11 Controlled drugs Each item of the table in clause 1 of Schedule 1 lists: (a) for the purposes of paragraph 301.1(1)(a) of the Code, a substance that is a controlled drug; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the controlled drug; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the controlled drug; and (d) for the purposes of paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity that is the trafficable quantity of the controlled drug. 12 Controlled plants Each item of the following table lists: (a) for the purposes of paragraph 301.2(1)(a) of the Code, a growing plant that is a controlled plant; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity that is a commercial quantity of the controlled plant; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity that is a marketable quantity of the controlled plant; and (d) for the purposes of paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity that is a trafficable quantity of the controlled plant. Controlled plants and quantities Item Controlled plant Commercial quantity Marketable quantity Trafficable quantity 1 Any plant of the genus Cannabis 250 kg or 1,000 plants 25 kg or 100 plants 250 g or 10 plants 13 Controlled precursors Each item of the following table lists: (a) for the purposes of paragraph 301.3(1)(a) of the Code, a substance that is a controlled precursor; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the controlled precursor; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the controlled precursor. Note: A salt or ester of a substance listed in the table is also a controlled precursor: see paragraph 301.3(1)(b) of the Code. Controlled precursors and quantities Item Controlled precursor Commercial quantity (kilograms) Marketable quantity (grams) 1A Alpha ‑ Phenylacetoacetamide (APAA) 2.75 915.0 1B Alpha ‑ Phenylacetoacetonitrile (APAAN) 1.76 587.0 1C 4 ‑ Anilino ‑ N ‑ phenethylpiperidine (ANPP) 0.006 2.77 1D Butyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 292.0 1E Butyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 1,194.0 1F Diethyl 2 ‑ (2 ‑ phenylacetyl)propanedioate (DEPAPD) 4.75 1,585.0 1 Ephedrine 1.2 400.0 2 Ergometrine 0.006 0.15 3 Ergotamine 0.01 0.25 3A Ethyl alpha ‑ phenylacetoacetate (EAPA) 3.28 1,094.0 3B Ethyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.3 261.0 3C Ethyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.18 1,051.0 3D Isobutyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 292.0 3E Isobutyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 1,194.0 3F Isopropyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.38 275.0 3G Isopropyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.39 1,123.0 4 Isosafrole 1.45 290.0 5 Lysergic acid 0.003 0.075 5A Methyl alpha ‑ phenylacetoacetate (MAPA) 3.06 1,020.0 6 3,4 ‑ Methylenedioxyphenylacetic acid 1.5 300.0 6AA 3 ‑ (3’,4’ ‑ Methylenedioxyphenyl) ‑ 2 ‑ methyl glycidic acid 1.33 266.0 6A 3 ‑ (3’, 4’ ‑ Methylenedioxyphenyl) ‑ 2 ‑ methyl glycidic acid, sodium salt (NaMDMG) 1.46 292.0 7 3,4 ‑ Methylenedioxyphenyl ‑ 2 ‑ propanone 0.75 150.0 7A Methyl 3 ‑ (3’, 4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate (MMDMG) 1.23 246.0 7B Methyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 2.96 980.0 7BA Norfentanyl 0.006 2.8 7C N ‑ Phenethyl ‑ 4 ‑ piperidone (NPP) 0.008 4.0 8 Phenylacetic acid 4.05 1,350.0 8AA 3 ‑ Phenyl ‑ 2 ‑ methyl glycidic acid 4.6 1,531.0 8A 3 ‑ Phenyl ‑ 2 ‑ methyl glycidic acid, sodium salt 5.17 1,720.0 8B N ‑ Phenyl ‑ 4 ‑ piperidinamine (4 ‑ AP) 0.008 3.8 9 Phenylpropanolamine 1.2 400.0 10 Phenyl ‑ 2 ‑ propanone 1.04 340.0 10A Phenyl ‑ 2 ‑ propanone bisulphite 2.64 880.0 10B 1 ‑ Phenylpropan ‑ 2 ‑ yl 4 ‑ methylbenzenesulfonate (para ‑ tosyl ‑ phenyl ‑ 2 ‑ propanol) 2.25 737.0 10C 4 ‑ Piperidone 0.008 3.8 11 Piperonal 1.6 320.0 11A Propyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.38 275.0 11B Propyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.39 1,123.0 12 Pseudoephedrine 1.2 400.0 13 Safrole 2.85 570.0 14 sec ‑ Butyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 292.0 15 sec ‑ Butyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 1,194.0 16 N ‑ (tert ‑ Butoxycarbonyl) ‑ 4 ‑ piperidone 0.015 7.6 17 tert ‑ Butyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 292.0 18 tert ‑ Butyl 4 ‑ (phenylamino)piperidine ‑ 1 ‑ carboxylate (1 ‑ boc ‑ 4 ‑ AP) 0.015 7.3 19 tert ‑ Butyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 1,194.0 14 Border controlled drugs (1) Each item of the table in subclause 1(1) of Schedule 2 lists: (a) for the purposes of paragraph 301.4(1)(a) of the Code, a substance that is a border controlled drug; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled drug; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled drug. Restricted listing (2) Each item of the table in subclause 1(2) of Schedule 2 lists: (a) for the purposes of paragraph 301.4(1)(a) and subsection 301.4(2) of the Code, a substance that is taken to be a border controlled drug only in relation to the following: (i) an offence against subsection 307.1(1), 307.2(1), 307.3(1) or 307.4(1) of the Code, if the offence relates to importing a substance; (ii) an offence against subsection 307.5(1), 307.6(1), 307.7(1), 307.8(1), 307.9(1) or 307.10(1) of the Code; (iii) an offence against subsection 309.12(1) or 309.13(1) of the Code, if the offence relates to procuring an individual to import a substance; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled drug; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled drug. 15 Border controlled plants Each item of the following table lists: (a) for the purposes of paragraph 301.5(1)(a) of the Code, a growing plant that is a border controlled plant; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) that is a commercial quantity of the border controlled plant; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) that is a marketable quantity of the border controlled plant. Border controlled plants and quantities Item Border controlled plant Commercial quantity Marketable quantity 1 Any plant of the genus Cannabis 250 kg or 1,000 plants 25 kg or 100 plants 2 Any plant of the genus Erythroxylon (also known as Erythroxylum ) from which cocaine can be extracted either directly or by chemical transformation 80 kg 3 Any plant of the genus Lophophora 4 Any plant of the species Papaver bracteatum 10 kg 5 Any plant of the species Papaver somniferum 10 kg 6 Any plant of the species Piptagenia peregrine 7 Any plant of the species Psilocybe 16 Border controlled precursors (1) Each item of the following table lists: (a) for the purposes of paragraph 301.6(1)(a) of the Code, a substance that is a border controlled precursor; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) that is the commercial quantity of the border controlled precursor; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the border controlled precursor. Note: A salt or ester of a substance listed in the table and an immediate precursor of a substance listed in the table are also border controlled precursors: see paragraphs 301.6(1)(b) and (c) of the Code. Border controlled precursors and quantities Item Border controlled precursor Commercial quantity (kilograms) Marketable quantity (grams) 1 N ‑ Acetylanthranilic acid 1A Alpha ‑ Phenylacetoacetamide (APAA) 2.74 7.3 1B Alpha ‑ Phenylacetoacetonitrile (APAAN) 1.76 4.7 1C 4 ‑ Anilino ‑ N ‑ phenethylpiperidine (ANPP) 0.006 0.006 2 Any plant of the species Ephedra 2AA Butyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 14.6 2AB Butyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 9.6 2A Chloroephedrine 1.153 3.07 2B Chloropseudoephedrine 1.153 3.07 2C Diethyl 2 ‑ (2 ‑ phenylacetyl)propanedioate (DEPAPD) 4.75 12.7 3 Ephedrine 1.2 3.2 4 Ergometrine 0.006 0.006 5 Ergotamine 0.01 0.01 5A Ethyl alpha ‑ phenylacetoacetate (EAPA) 3.28 8.8 5B Ethyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.3 13.0 5C Ethyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.18 8.5 5D Isobutyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 14.6 5E Isobutyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 9.6 5F Isopropyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.38 13.8 5G Isopropyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.39 9.1 6 Isosafrole 1.45 1.45 7 Lysergic acid 0.003 0.003 7A Methyl alpha ‑ phenylacetoacetate (MAPA) 3.06 8.2 7AA 3 ‑ (3’,4’ ‑ Methylenedioxyphenyl) ‑ 2 ‑ methyl glycidic acid 1.33 13.3 7B 3 ‑ (3’, 4’ ‑ Methylenedioxyphenyl) ‑ 2 ‑ methyl glycidic acid, sodium salt (NaMDMG) 1.46 14.6 8 3,4 ‑ Methylenedioxyphenyl ‑ 2 ‑ propanone 0.75 0.75 8A Methyl 3 ‑ (3’, 4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate (MMDMG) 1.23 12.3 8B Methyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 2.96 7.9 8BA Norfentanyl 0.006 0.006 8C N ‑ Phenethyl ‑ 4 ‑ piperidone (NPP) 0.008 0.008 9 Phenylacetic acid 4.05 10.8 9AA 3 ‑ Phenyl ‑ 2 ‑ methyl glycidic acid 4.6 12.2 9A 3 ‑ Phenyl ‑ 2 ‑ methyl glycidic acid, sodium salt 5.17 13.7 9B N ‑ Phenyl ‑ 4 ‑ piperidinamine (4 ‑ AP) 0.008 0.008 10 Phenylpropanolamine 1.2 3.2 11 Phenyl ‑ 2 ‑ propanone 1.04 2.7 11A Phenyl ‑ 2 ‑ propanone bisulphite 2.64 7.04 11B 1 ‑ Phenylpropan ‑ 2 ‑ yl 4 ‑ methylbenzenesulfonate (para ‑ tosyl ‑ phenyl ‑ 2 ‑ propanol) 2.25 5.9 11C 4 ‑ Piperidone 0.008 0.008 12 Piperonal 1.6 1.6 12A Propyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.38 13.8 12B Propyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.39 9.1 13 Pseudoephedrine 1.2 3.2 14 Safrole 2.85 2.85 15 sec ‑ Butyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 14.6 16 sec ‑ Butyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 9.6 17 N ‑ (tert ‑ Butoxycarbonyl) ‑ 4 ‑ piperidone 0.015 0.015 18 tert ‑ Butyl 3 ‑ (3’,4’ ‑ methylenedioxyphenyl) ‑ 2 ‑ methyl glycidate 1.46 14.6 19 tert ‑ Butyl 4 ‑ (phenylamino) piperidine ‑ 1 ‑ carboxylate (1 ‑ boc ‑ 4 ‑ AP) 0.015 0.015 20 tert ‑ Butyl 3 ‑ phenyl ‑ 2 ‑ methyl glycidate 3.61 9.6 Restricted listing (2) Each item of the following table lists: (a) for the purposes of paragraph 301.6(1)(a) and subsection 301.6(1A) of the Code, a substance that is taken to be a border controlled precursor only in relation to the following: (i) an offence against subsection 307.11(1), 307.12(1) or 307.13(1) of the Code, if the offence relates to importing a substance; (ii) an offence against subsection 309.14(1) or 309.15(1) of the Code, if the offence relates to procuring an individual to import a substance; and (b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled precursor; and (c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled precursor. Note: For a salt, ester or immediate precursor of a substance listed in the table, see paragraphs 301.6(1)(b) and (c) and subsection 301.6(1B) of the Code. Border controlled precursors and quantities—restricted listing Item Border controlled precursor Commercial quantity (kilograms) Marketable quantity (grams) 1 Alpha ‑ Methyl ‑ 1,3 ‑ benzodioxole ‑ 5 ‑ propanal (Helional) 1.0 1.0 2 Benzaldehyde 1.85 4.8 3 Hypophosphorous acid (Phosphinic acid) 1.2 3.2 4 Iodine 1.2 3.2 5 Methylamine 0.6 1.6 Division 2 — Psychoactive substances 17 Importing psychoactive substances For the purposes of paragraph 320.2(2)(l) of the Code, a substance that is imported into Australia in accordance with the conditions set out in section 19 of this instrument is prescribed. 18 Importing substances represented to be serious drug alternatives For the purposes of paragraph 320.3(3)(f) of the Code, a substance that is imported into Australia in accordance with the conditions set out in section 19 of this instrument is prescribed. 19 Conditions for importing certain substances (1) For the purposes of sections 17 and 18, the conditions are that: (a) the person importing the substance (the importer ) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956 ; and (b) the importer is covered by subsection (2); and (c) before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes: (i) the identity and amount of the substance being imported; and (ii) the purpose of the importation; and (iii) a 30 ‑ day period during which the importation is likely to occur; and (iv) the importer’s name and import licence number; and (v) if paragraph (2)(a), (d), (e) or (f) applies and the importer is employed by the body mentioned in the applicable paragraph—the name of the importer’s employer; and (vi) any other information required by the Health Secretary. (2) For the purposes of paragraph (1)(b), the importer is covered by this subsection if: (a) the importer is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or (b) the importer is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or (c) the importer is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or (d) the importer is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or (e) the importer is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or (f) all of the following apply: (i) the importer is, or is employed by, an entity that imports drugs (within the meaning of subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956 ) on behalf of a person or body mentioned in paragraph (a), (b), (c), (d) or (e); (ii) the person or body holds a licence of a kind mentioned in paragraph (1)(a); (iii) the importer is importing the substance at the written request of the person or body. (3) For the purposes of paragraph (1)(c), the Health Secretary may determine: (a) information to be included in a notice; and (b) the way a notice may be given to the Health Secretary or an authorised person. Division 3 — Cross ‑ border firearms trafficking 20 Firearm law For the purposes of the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the following laws are prescribed: (a) the Firearms Act 1996 (NSW); (b) the Firearms Act 1996 (Vic.); (c) the Weapons Act 1990 (Qld); (d) the Firearms Act 1973 (WA); (e) the Firearms Act 2015 (SA); (f) the Firearms Act 1996 (Tas.); (g) the Firearms Act 1996 (ACT); (h) the Firearms Act 1997 (NT); (i) the Firearms and Prohibited Weapons Act 1997 (Norfolk Island); (j) any regulations made under any of the Acts referred to in paragraphs (a) to (i). Division 4 — Community safety orders 20A Serious offender unable to engage legal representative in community safety order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control For the purposes of paragraph 395.34(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond a serious offender’s control in relation to a community safety order proceeding: (a) the offender’s financial circumstances; (b) whether the offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding; (c) whether the offender has made any efforts to obtain legal aid or legal assistance, and the outcomes of any such efforts; (d) any other matter that the Court considers relevant. 20B Sharing information—prescribed persons For the purposes of subsections 395.44(1) and (4) of the Code, the following persons are prescribed: (a) an AFP employee (within the meaning of the Australian Federal Police Act 1979 ); (b) a member of the police force or police service of a State or Territory; (c) an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole; (d) a person who provides services for, or on behalf of: (i) a State or Territory; or (ii) an authority of a State or Territory; in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole; (e) a person who provides services for, or on behalf of, the Commonwealth in relation to a person (the service recipient ) if: (i) a community safety order is in force in relation to the service recipient; or (ii) the Immigration Minister has made, or is considering making, an application for a community safety order in relation to the service recipient; (f) the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory; (g) a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983 ) or of a similar body established under a law of a State or Territory; (h) the Director ‑ General of Security, a Deputy Director ‑ General of Security, an ASIO employee (within the meaning of the Australian Security Intelligence Organisation Act 1979 ) or an ASIO affiliate (within the meaning of that Act); (i) an APS employee in a Department administered by: (i) the Immigration Minister; or (ii) the Minister administering the Australian Passports Act 2005 ; (j) a person: (i) who is an authorised officer (within the meaning of Division 9A of Part IB of the Crimes Act 1914 ); or (ii) who, under a delegation from such an authorised officer, exercises powers or performs functions of the authorised officer under Division 9A of Part IB of the Crimes Act 1914 ; (k) a person who is a relevant expert and who is: (i) appointed by the Immigration Minister under section 395.43 of the Code; or (ii) otherwise engaged by the Immigration Minister, or a person on behalf of the Immigration Minister; to assess the risk of a serious offender committing a serious violent or sexual offence for the purposes of Division 395 of the Code (whether or not an application for a community safety order has been made); (l) a person who is engaged as a consultant or contractor to perform services for the Department administered by the Immigration Minister; (m) a person who is: (i) engaged or employed by a person to whom paragraph (l) or this paragraph applies; and (ii) performing services for the Department administered by the Immigration Minister in connection with that engagement or employment. Part 4 — National infrastructure 21 Dangerous or harmful substances and things that must not be carried by post For the purposes of subparagraph 471.15(1)(b)(ii) of the Code, the following are dangerous or harmful substances or things that must not, without exception, be carried by post: (a) gas that is so toxic or corrosive to humans as to pose a hazard to health; (b) a thermally unstable substance that is likely to undergo a strongly exothermic decomposition; (c) a substance that ignites or self ‑ heats when in contact with air. Part 5 — Application, saving and transitional provisions Division 1 — Provisions for this instrument as originally made 22 Things done under the Criminal Code Regulations 2002 (1) If: (a) a thing was done for a particular purpose under the Criminal Code Regulations 2002 as in force immediately before those Regulations were repealed; and (b) the thing could be done for that purpose under this instrument; the thing has effect for the purposes of this instrument as if it had been done for that purpose under this instrument. (2) Without limiting subsection (1), a reference in that subsection to a thing being done includes a reference to a notice, application or other instrument being given or made. 23 Conduct, event, circumstances occurring before commencement (1) To avoid doubt, a function or duty may be performed, or a power exercised, under this instrument in relation to conduct engaged in, an event that occurred, or a circumstance that arose, before this section commences. (2) This section does not limit section 22 of this instrument or section 7 of the Acts Interpretation Act 1901 (as that Act applies in relation to this instrument because of paragraph 13(1)(a) of the Legislation Act 2003 ). Schedule 1 — Controlled drugs Note: See section 11. 1 Controlled drugs and quantities The following table lists substances that are controlled drugs and the quantities of those drugs that are commercial quantities, marketable quantities and trafficable quantities. Note: A drug analogue of a substance listed in the table is also a controlled drug (see paragraph 301.1(1)(b) of the Code). Controlled drugs and quantities Item Controlled drug Commercial quantity (kilograms) Marketable quantity (grams) Trafficable quantity (grams) 1 Acetorphine 2.0 250.0 2.0 2 4 ‑ Acetoxy ‑ N, N ‑ dimethyltryptamine (4 ‑ AcO ‑ DMT) 2.0 250.0 2.0 3 4 ‑ Acetoxy ‑ N ‑ methyl ‑ N ‑ ethyltryptamine (4 ‑ AcO ‑ MET) 2.0 250.0 2.0 4 Acetyl ‑ alpha ‑ methylfentanyl 0.005 2.5 0.005 5 Acetylcodeine 2.0 250.0 2.0 6 Acetyldihydrocodeine 2.0 250.0 2.0 7 Acetylmethadol 2.0 250.0 2.0 8 Allylprodine 2.0 250.0 2.0 9 Alphacetylmethadol 10.0 5,000.0 10.0 10 Alphameprodine 0.2 100.0 0.2 11 Alphamethadol 0.2 100.0 0.2 12 alpha ‑ Methylfentanyl 0.005 2.5 0.005 13 alpha ‑ Methylthiofentanyl 0.005 2.5 0.005 14 Alphaprodine 25.0 12,500.0 25.0 15 alpha ‑ Pyrrolidinobutiophenone (α ‑ PBP) 0.75 250.0 0.75 16 alpha ‑ Pyrrolidinopropiophenone (α ‑ PPP) 0.75 250.0 0.75 17 alpha ‑ Pyrrolidinovalerophenone (α ‑ PVP) 0.75 250.0 0.75 18 5 ‑ (2 ‑ Aminopropyl) ‑ 2,3 ‑ dihydro ‑ 1h ‑ indene (5 ‑ APDI) 0.75 250.0 0.75 19 6 ‑ (2 ‑ Aminopropyl) ‑ 2,3 ‑ dihydrobenzofuran (6 ‑ APDB) 0.75 250.0 0.75 20 Amphetamine 0.75 250.0 2.0 21 Anileridine 25.0 12,500.0 25.0 22 Barbiturates 5.0 5.0 23 Benzethidine 10.0 5,000.0 10.0 24 1 ‑ (Benzofuran ‑ 6 ‑ yl) propan ‑ 2 ‑ amine (6 ‑ APB) 0.75 250.0 0.75 24A Benzoylbenzylfentanyl 0.005 2.5 0.005 25 Benzoylecgonine 2.0 250.0 2.0 25A Benzoylfentanyl 0.005 2.5 0.005 25B Benzylfentanyl 0.005 2.5 0.005 25C Benzylfuranylfentanyl 0.005 2.5 0.005 26 Benzylmorphine 5.0 2,500.0 5.0 27 Benzylpiperazine 0.75 250.0 2.0 28 Betacetylmethadol 5.0 2,500.0 5.0 29 beta ‑ Hydroxyfentanyl 0.005 2.5 0.005 30 beta ‑ Hydroxy ‑ 3 ‑ methylfentanyl 0.005 2.5 0.005 31 beta ‑ Keto ‑ methylbenzodioxolylpentanamine (pentylone) 0.75 250.0 0.75 32 beta ‑ Keto ‑ N ‑ methyl ‑ 3,4 ‑ benzodioxyolylbutanamine (butylone) 0.75 250.0 0.75 33 Betameprodine 5.0 2,500.0 5.0 34 Betamethadol 5.0 2,500.0 5.0 35 Betaprodine 5.0 2,500.0 5.0 36 Bezitramide 5.0 2,500.0 5.0 36A Bromazolam 5.0 1,250.0 30.0 37 2 ‑ Bromoamphetamine 0.75 250.0 0.75 38 3 ‑ Bromoamphetamine 0.75 250.0 0.75 39 4 ‑ Bromoamphetamine 0.75 250.0 0.75 40 4 ‑ Bromo ‑ 2,5 ‑ dimethoxyamphetamine 0.5 100.0 0.5 41 2 ‑ Bromo ‑ 5 ‑ methoxymethcathinone 0.75 250.0 0.75 42 2 ‑ Bromomethamphetamine 0.75 250.0 0.75 43 3 ‑ Bromomethamphetamine 0.75 250.0 0.75 44 4 ‑ Bromomethamphetamine 0.75 250.0 0.75 45 2 ‑ Bromomethcathinone 0.75 250.0 0.75 46 3 ‑ Bromomethcathinone 0.75 250.0 0.75 47 4 ‑ Bromomethcathinone 0.75 250.0 0.75 48 Bufotenine 2.0 250.0 2.0 49 Bupropion 0.75 250.0 0.75 49A Butonitazene 0.005 2.5 0.005 50 Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) 125.0 25,000.0 250.0 51 Cannabis resin 125.0 25,000.0 20.0 52 Cathinone 0.75 250.0 0.75 53 1 ‑ (4 ‑ Chloro ‑ 2,5 ‑ dimethoxyphenyl) ‑ 2 ‑ ethenamine (2C ‑ C) 0.5 100.0 0.5 54 2 ‑ Chloroamphetamine 0.75 250.0 0.75 55 3 ‑ Chloroamphetamine 0.75 250.0 0.75 56 4 ‑ Chloroamphetamine 0.75 250.0 0.75 57 2 ‑ Chloromethamphetamine 0.75 250.0 0.75 58 3 ‑ Chloromethamphetamine 0.75 250.0 0.75 59 4 ‑ Chloromethamphetamine 0.75 250.0 0.75 60 4 ‑ Chloro ‑ N ‑ ethylamphetamine 0.75 250.0 0.75 61 2 ‑ Chloromethcathinone 0.75 250.0 0.75 62 3 ‑ Chloromethcathinone 0.75 250.0 0.75 63 4 ‑ Chloromethcathinone 0.75 250.0 0.75 64 4 ‑ Chlorophenyl ‑ 1 ‑ methoxypropan ‑ 2 ‑ amine 0.75 250.0 0.75 65 Chlorphentermine 2.0 250.0 2.0 66 Clonitazene 0.005 2.5 0.005 67 Cocaine 2.0 250.0 2.0 68 Codeine 10.0 5,000.0 10.0 69 Codeine ‑ N ‑ oxide 10.0 5,000.0 10.0 70 Codoxime 10.0 5,000.0 10.0 70A N ‑ Desethyl etonitazene 0.005 2.5 0.005 70B N ‑ Desethyl isotonitazene 0.005 2.5 0.005 70C N ‑ Desethyl protonitazene 0.005 2.5 0.005 71 Desomorphine 2.0 250.0 2.0 72 Dexamphetamine 2.0 250.0 2.0 73 Dextromoramide 2.0 250.0 2.0 74 Diampromide 5.0 2,500.0 5.0 75 Diethylpropion (N, N ‑ Diethylcathinone) 5.0 2,500.0 5.0 76 Diethylthiambutene 5.0 2,500.0 5.0 77 N,N ‑ Diethyltryptamine 2.0 250.0 2.0 78 Difenoxin 2.0 250.0 2.0 79 1 ‑ (2,3 ‑ Dihydro ‑ 1 ‑ benzofuran ‑ 5 ‑ yl)propan ‑ 2 ‑ amine (5 ‑ APDB) 0.75 250.0 0.75 80 Dihydrocodeine 10.0 5,000.0 10.0 81 Dihydromorphine 10.0 5,000.0 10.0 82 Dimenoxadol 10.0 5,000.0 10.0 83 Dimepheptanol 10.0 5,000.0 10.0 84 2,5 ‑ Dimethoxy ‑ 4 ‑ bromophenethylamine (2C ‑ B) 0.5 100.0 0.5 85 2,5 ‑ Dimethoxy ‑ 4 ‑ ethylphenethylamine (2C ‑ E) 0.5 100.0 0.5 86 2,5 ‑ Dimethoxy ‑ 4 ‑ iodophenethylamine (2C ‑ I) 0.5 100.0 0.5 87 2,5 ‑ Dimethoxy ‑ 4 ‑ methylamphetamine (STP, DOM) 0.75 250 0.75 88 2,5 ‑ Dimethoxy ‑ 4 ‑ methylphenethylamine (2C ‑ D) 0.5 100.0 0.5 89 2,5 ‑ Dimethoxy ‑ 4 ‑ nitrophenethylamine (2C ‑ N) 0.5 100.0 0.5 90 2,5 ‑ Dimethoxy ‑ 4 ‑ (n) ‑ propylphenethylamine (2C ‑ P) 0.5 100.0 0.5 91 3,4 ‑ Dimethoxymethcathinone 0.75 250.0 0.75 92 1 ‑ Dimethylamino ‑ 1,2 ‑ diphenylethane 5.0 2,500.0 5.0 93 N,N ‑ Dimethylamphetamine 0.75 250.0 0.75 94 N, N ‑ Dimethylcathinone 0.75 250.0 0.75 95 1,1 ‑ Dimethylheptyl ‑ 11 ‑ hydroxytetrahydrocannabinol (HU ‑ 210) 5.0 1,000.0 5.0 96 3,4 ‑ Dimethylmethcathinone 0.75 250.0 0.75 97 Dimethylthiambutene 20.0 10,000.0 20.0 98 N,N ‑ Dimethyltryptamine 2.0 250.0 2.0 99 Dioxaphetyl butyrate 2.0 250.0 2.0 99A Dipentylone (N,N ‑ dimethylpentylone) 0.75 250.0 0.75 100 Diphenoxylate 2.0 250.0 2.0 101 Dipipanone 10.0 5,000.0 10.0 102 Drotebanol 2.0 250.0 2.0 103 Ecgonine 10.0 5,000.0 10.0 104 Ethchlorvynol 50.0 50.0 105 Ethinamate 50.0 50.0 106 N ‑ Ethylcathinone 0.75 250.0 0.75 106A Ethylene etonitazene 0.005 2.5 0.005 106B Ethyleneoxynitazene 0.005 2.5 0.005 107 Ethylmethylthiambutene 10.0 5,000.0 10.0 108 Ethylmorphine 2.0 250.0 2.0 109 3 ‑ (2 ‑ Ethylphenyl) ‑ 2 ‑ methyl ‑ quinazolin ‑ 4 ‑ one (Etaqualone) 5.0 5.0 109A Etodesnitazene (etazene) 0.005 2.5 0.005 110 Etonitazene 0.005 2.5 0.005 110A Etonitazepipne (N ‑ piperidinyl etonitazene) 0.005 2.5 0.005 110B Etonitazepyne (N ‑ pyrrolidino etonitazene) 0.005 2.5 0.005 111 Etorphine 5.0 2,500.0 5.0 112 Etoxeridine 5.0 2,500.0 5.0 113 Fentanyl 0.005 2.5 0.005 113A Flunitazene 0.005 2.5 0.005 114 4 ‑ Fluoro ‑ 2,5 ‑ dimethoxyphenethylamine (2C ‑ F) 0.5 100.0 0.5 115 2 ‑ Fluoroamphetamine 0.75 250.0 0.75 116 3 ‑ Fluoroamphetamine 0.75 250.0 0.75 117 4 ‑ Fluoroamphetamine 0.75 250.0 0.75 117A 2 ‑ Fluorodeschloroketamine (2 ‑ FDCK) 1.0 500.0 3.0 118 2 ‑ Fluoromethamphetamine 0.75 250.0 0.75 119 3 ‑ Fluoromethamphetamine 0.75 250.0 0.75 120 4 ‑ Fluoromethamphetamine 0.75 250.0 0.75 121 2 ‑ Fluoromethcathinone 0.75 250.0 0.75 122 3 ‑ Fluoromethcathinone 0.75 250.0 0.75 123 4 ‑ Fluoromethcathinone 0.75 250.0 0.75 123A Furanylfentanyl 0.005 2.5 0.005 124 Furethidine 1.0 500.0 1.0 125 Gammabutyrolactone (GBL) 1.0 250.0 0.5 126 Glutethimide 50.0 50.0 127 Heroin (diacetylmorphine) 1.5 250.0 2.0 128 Hydrocodone 2.0 250.0 2.0 129 Hydromorphinol 2.0 250.0 2.0 130 Hydromorphone 2.0 250.0 2.0 131 Hydroxyamphetamine 2.0 250.0 2.0 132 4 ‑ Hydroxybutanoic acid (GHB) 1.0 250.0 0.5 133 p ‑ Hydroxyephedrine 2.0 250.0 2.0 134 Hydroxypethidine 0.75 250.0 0.75 135 2 ‑ Iodoamphetamine 0.75 250.0 0.75 136 3 ‑ Iodoamphetamine 0.75 250.0 0.75 137 4 ‑ Iodoamphetamine 0.75 250.0 0.75 138 2 ‑ Iodomethamphetamine 0.75 250.0 0.75 139 3 ‑ Iodomethamphetamine 0.75 250.0 0.75 140 4 ‑ Iodomethamphetamine 0.75 250.0 0.75 141 2 ‑ Iodomethcathinone 0.75 250.0 0.75 142 3 ‑ Iodomethcathinone 0.75 250.0 0.75 143 4 ‑ Iodomethcathinone 0.75 250.0 0.75 144 Isomethadone 2.0 250.0 2.0 145 4 ‑ Isopropoxy ‑ 2,5 ‑ dimethoxyphenethylamine (2C ‑ O ‑ 4) 0.5 100.0 0.5 145A Isotodesnitazene 0.005 2.5 0.005 145B Isotonitazene 0.005 2.5 0.005 146 Ketamine 1.0 500.0 3.0 147 Ketobemidone 2.0 250.0 2.0 148 Levomethorphan 2.0 250.0 2.0 149 Levophenacylmorphan 2.0 250.0 2.0 150 Levorphanol, but not including dextrorphan 1.0 500.0 1.0 151 Lysergamides 0.01 0.01 152 Lysergide (LSD) 0.002 0.05 0.002 153 Meprobamate 50.0 50.0 154 Mescaline 7.5 3.75 7.5 155 Metazocine 7.0 3,500.0 7.0 156 Methadone 2.0 250.0 2.0 157 Methamphetamine 0.75 250.0 2.0 158 Methaqualone 5.0 5.0 159 Methcathinone 0.75 250.0 2.0 160 Methorphan, but not including dextromethorphan 2.0 250.0 2.0 161 4’ ‑ Methoxy ‑ alpha ‑ pyrrolidinopropiophenone (MOPPP) 0.75 250.0 0.75 162 4 ‑ Methoxyamphetamine 0.75 250.0 0.75 163 4 ‑ Methoxymethamphetamine 0.75 250.0 0.75 164 4 ‑ Methoxymethcathinone 0.75 250.0 0.75 165 4’ ‑ Methyl ‑ alpha ‑ pyrrolidinobutiophenone (MPBP) 0.75 250.0 0.75 166 4’ ‑ Methyl ‑ alpha ‑ pyrrolidinohexiophenone (MPHP) 0.75 250.0 0.75 167 4’ ‑ Methyl ‑ alpha ‑ pyrrolidinopropiophenone (MPPP) 0.75 250.0 0.75 168 2 ‑ Methylamino ‑ 1 ‑ phenylbutan ‑ 1 ‑ one (buphedrone) 0.75 250.0 0.75 169 4 ‑ Methylamphetamine 0.75 250.0 0.75 170 N ‑ Methyl butylone 0.75 250.0 0.75 171 Methyldesorphine 2.0 250.0 2.0 172 Methyldihydromorphine 2.0 250.0 2.0 173 3,4 ‑ Methylenedioxyamphetamine (MDA) 0.75 100.0 0.5 174 3,4 ‑ Methylenedioxymethamphetamine (MDMA) 0.5 100.0 0.5 175 3,4 ‑ Methylenedioxyethcathinone (MDEC) 0.75 250.0 0.75 176 3,4 ‑ Methylenedioxymethcathinone (MDMC) 0.75 250.0 0.75 176A Methylenedioxynitazene (2 ‑ (2 ‑ (benzo[d] [1,3]dioxol ‑ 5 ‑ ylmethyl) ‑ 5 ‑ nitro ‑ 1H ‑ benzo [d]imidazol ‑ 1 ‑ yl) ‑ N,N ‑ diethylethan ‑ 1 ‑ amine) 0.005 2.5 0.005 177 3,4 ‑ Methylenedioxypyrovalerone (MDPV) 0.75 250.0 0.75 178 3’,4’ ‑ Methylenedioxy ‑ alpha ‑ pyrrolidinobutiophenone (MDPBP) 0.75 250.0 0.75 179 3’,4’ ‑ Methylenedioxy ‑ alpha ‑ pyrrolidinopropiophenone (MDPPP) 0.75 250.0 0.75 180 4 ‑ Methylethcathinone 0.75 250.0 0.75 181 3 ‑ Methylfentanyl 0.005 2.5 0.005 182 4 ‑ Methylmethamphetamine 0.75 250.0 0.75 183 4 ‑ Methylmethcathinone (4 ‑ MMC) 0.75 250.0 2.0 184 Methylphenidate 2.0 250.0 2.0 185 1 ‑ Methyl ‑ 4 ‑ phenyl ‑ 4 ‑ propionoxypiperidine (MPPP) 2.0 250.0 2.0 186 4 ‑ Methylthioamphetamine (4 ‑ MTA) 0.75 250.0 0.75 187 4 ‑ Methylthiobutylamphetamine (4 ‑ MTBA) 0.75 250.0 0.75 188 4 ‑ Methylthiodimethamphetamine (4 ‑ MTDMA) 0.75 250.0 0.75 189 4 ‑ Methylthioethylamphetamine (4 ‑ MTEA) 0.75 250.0 0.75 190 3 ‑ Methylthiofentanyl 0.005 2.5 0.005 191 4 ‑ Methylthiomethamphetamine (4 ‑ MTMA) 0.75 250.0 0.75 192 4 ‑ Methylthiopropylamphetamine (4 ‑ MTPA) 0.75 250.0 0.75 193 Methyprylon 50.0 50.0 193A Metodesnitazene (metazene) 0.005 2.5 0.005 193B Metonitazene 0.005 2.5 0.005 194 Metopon 2.0 250.0 2.0 195 Monoacetylmorphines 2.0 250.0 2.0 196 Moramide 2.0 250.0 2.0 197 Morphan, but not including dextrorphan 2.0 250.0 2.0 198 Morpheridine 2.0 250.0 2.0 199 Morphine 1.5 250.0 1.5 200 Morphine ‑ N ‑ oxide 2.0 250.0 2.0 201 Myrophine 20.0 20.0 202 Nicocodine 2.0 250.0 2.0 203 Nicodicodine 2.0 250.0 2.0 204 Nicomorphine 2.0 250.0 2.0 205 Noracymethadol 2.0 250.0 2.0 206 Norcodeine 2.0 250.0 2.0 207 Norlevorphanol 2.0 250.0 2.0 208 Normethadone 5.0 2,500.0 5.0 209 Normorphine 20.0 20.0 210 Norpipanone 10.0 5,000.0 10.0 211 Opium 20.0 10,000.0 20.0 212 Oripavine 2.0 250.0 2.0 213 Oxycodone 5.0 2,500.0 5.0 214 Oxymorphone 2.0 250.0 2.0 215 para ‑ Fluorofentanyl 0.005 2.5 0.005 216 Pentazocine 20.0 20.0 217 Pethidine 10.0 5,000.0 10.0 218 Phenadoxone 10.0 5,000.0 10.0 219 Phenampromide 10.0 5,000.0 10.0 220 Phenazocine 1.0 500.0 1.0 221 Phencyclidine 2.0 250.0 2.0 222 Phendimetrazine 5.0 2,500.0 5.0 223 Phenmetrazine 5.0 2,500.0 5.0 224 Phenomorphan 5.0 2,500.0 5.0 225 Phenoperidine 1.0 500.0 1.0 226 Phentermine 5.0 2,500.0 5.0 227 1 ‑ Phenylethyl ‑ 4 ‑ phenyl ‑ 4 ‑ acetoxypiperidine (PEPAP) 2.0 250.0 2.0 227A 3 ‑ Phenylpropanoylfentanyl 0.005 2.5 0.005 228 Pholcodine 5.0 2,500.0 5.0 229 Piminodine 10.0 5,000.0 10.0 230 Pipradrol 1.0 500.0 1.0 231 Piritramide 1.0 500.0 1.0 232 Proheptazine 1.0 500.0 1.0 233 Properidine 25.0 12,500.0 25.0 234 Propiram 10.0 5,000.0 10.0 234A Protonitazene 0.005 2.5 0.005 234B Protonitazepyne (N ‑ pyrrolidino protonitazene) 0.005 2.5 0.005 235 Psilocine 2.0 1,000.0 2.0 236 Psilocybine 2.0 1,000.0 2.0 237 Pyrovalerone 0.75 250.0 0.75 237A Secofentanyl 0.005 2.5 0.005 238 Tetrahydrocannabinols (THC) 5.0 1,000.0 2.0 239 Thebacon 2.0 250.0 2.0 240 Thebaine 2.0 250.0 2.0 241 Thiofentanyl 0.005 2.5 0.005 241A Thiofuranylfentanyl 0.005 2.5 0.005 242 Trimeperidine 10.0 5,000.0 10.0 243 2,3,4 ‑ Trimethoxyamphetamine 0.75 250.0 0.75 244 2,3,5 ‑ Trimethoxyamphetamine 0.75 250.0 0.75 245 2,3,6 ‑ Trimethoxyamphetamine 0.75 250.0 0.75 246 2,4,5 ‑ Trimethoxyamphetamine 0.75 250.0 0.75 247 2,4,6 ‑ Trimethoxyamphetamine 0.75 250.0 0.75 248 3,4,5 ‑ Trimethoxyamphetamine 0.75 250.0 0.75 249 2,4,5 ‑ Trimethoxyphenethylamine (2C ‑ O) 0.5 100.0 0.5 Schedule 2 — Border controlled drugs Note: See section 14. 1 Border controlled drugs and quantities (1) The following table lists substances that are border controlled drugs and the quantities of those drugs that are commercial quantities and marketable quantities. Note: A drug analogue of a substance listed in the table is also a border controlled drug (see paragraph 301.4(1)(b) of the Code). Border controlled drugs and quantities Item Border controlled drug Commercial quantity (kilograms) Marketable quantity (grams) 1 Acetorphine 2.0 2.0 2 Acetyl ‑ alpha ‑ methylfentanyl 0.005 0.005 3 Acetylcodeine 2.0 2.0 4 Acetyldihydrocodeine 2.0 2.0 5 Acetylmethadol 2.0 2.0 6 Allylprodine 2.0 2.0 7 Alphacetylmethadol 10.0 10.0 8 Alphameprodine 0.2 0.2 9 Alphamethadol 0.2 0.2 10 alpha ‑ Methylfentanyl 0.005 0.005 11 alpha ‑ Methylthiofentanyl 0.005 0.005 12 Alphaprodine 25.0 25.0 13 3 ‑ (2 ‑ Aminopropyl)indole (alpha ‑ methyltryptamine (AMT)) 2.0 2.0 14 5 ‑ (2 ‑ Aminopropyl) ‑ 2,3 ‑ dihydro ‑ 1h ‑ indene (5 ‑ APDI) 0.75 0.5 15 Amphecloral 2.0 2.0 16 Amphetamine 0.75 2.0 17 Anileridine 25.0 25.0 18 Barbiturates 5.0 50.0 19 Benzethidine 10.0 10.0 20 1 ‑ (Benzofuran ‑ 6 ‑ yl) propan ‑ 2 ‑ amine (6 ‑ APB) 0.75 0.5 20A Benzoylbenzylfentanyl 0.005 0.005 21 Benzoylecgonine 2.0 2.0 21A Benzoylfentanyl 0.005 0.005 21B Benzylfentanyl 0.005 0.005 21C Benzylfuranylfentanyl 0.005 0.005 22 Benzylmorphine 5.0 5.0 23 Benzylpiperazine 0.75 2.0 24 Betacetylmethadol 5.0 5.0 25 beta ‑ Hydroxyfentanyl 0.005 0.005 26 beta ‑ Hydroxy ‑ 3 ‑ methylfentanyl 0.005 0.005 27 beta ‑ Keto ‑ N ‑ methyl ‑ 3,4 ‑ benzodioxyolylbutanamine (butylone) 0.75 2.0 28 Betameprodine 5.0 5.0 29 Betamethadol 5.0 5.0 30 Betaprodine 5.0 5.0 31 Bezitramide 5.0 5.0 31A Bromazolam 5.0 30.0 32 4 ‑ Bromo ‑ 2,5 ‑ dimethoxyamphetamine 0.5 0.5 33 2 ‑ (4 ‑ bromo ‑ 2,5 ‑ dimethoxyphenyl) ‑ N ‑ [(2 ‑ methoxyphenyl) methyl]ethanamine (25 ‑ B ‑ NBOMe) 0.002 0.002 34 Bufotenine 2.0 2.0 34A Butonitazene 0.005 0.005 35 Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant) 2.0 2.0 36 Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) 100.0 25,000.0 37 Cannabis resin 50.0 20.0 38 Cathinone 0.75 2.0 39 1 ‑ (4 ‑ Chloro ‑ 2,5 ‑ dimethoxyphenyl) ‑ 2 ‑ ethenamine (2C ‑ C) 0.5 0.5 40 2 ‑ (4 ‑ chloro ‑ 2,5 ‑ dimethoxyphenyl) ‑ N ‑ [(2 ‑ methoxyphenyl) methyl]ethanamine (25 ‑ C ‑ NBOMe) 0.002 0.002 41 Chlorphentermine 2.0 2.0 42 Clonitazene 0.005 0.005 43 Cocaine 2.0 2.0 44 Codeine 10.0 10.0 45 Codeine ‑ N ‑ oxide 10.0 10.0 46 Codoxime 10.0 10.0 46A N ‑ Desethyl etonitazene 0.005 0.005 46B N ‑ Desethyl isotonitazene 0.005 0.005 46C N ‑ Desethyl protonitazene 0.005 0.005 47 Desomorphine 2.0 2.0 48 Dexamphetamine 2.0 2.0 49 Dextromoramide 2.0 2.0 50 Diampromide 5.0 5.0 51 Diethylpropion (N, N ‑ Diethylcathinone) 5.0 5.0 52 Diethylthiambutene 5.0 5.0 53 N,N ‑ Diethyltryptamine 2.0 2.0 54 Difenoxin 2.0 2.0 55 Dihydrocodeine 10.0 10.0 56 Dihydromorphine 10.0 10.0 57 Dimenoxadol 10.0 10.0 58 Dimepheptanol 10.0 10.0 59 2,5 ‑ Dimethoxy ‑ 4 ‑ bromophenethylamine (2C ‑ B) 0.5 0.5 60 2,5 ‑ Dimethoxy ‑ 4 ‑ (n) ‑ butylthiophenethylamine (2C ‑ T ‑ 9) 0.5 0.5 61 2,5 ‑ Dimethoxy ‑ 4 ‑ ethylphenethylamine (2C ‑ E) 0.5 0.5 62 2,5 ‑ Dimethoxy ‑ 4 ‑ ethylthiophenethylamine (2C ‑ T ‑ 2) 0.5 0.5 63 2,5 ‑ Dimethoxy ‑ 4 ‑ iodophenethylamine (2C ‑ I) 0.5 0.5 64 2,5 ‑ Dimethoxy ‑ 4 ‑ (β ‑ isobutylthio)phenethylamine (2C ‑ T ‑ 17) 0.5 0.5 65 2,5 ‑ Dimethoxy ‑ 4 ‑ isopropylthiophenethylamine (2C ‑ T ‑ 4) 0.5 0.5 66 2,5 ‑ Dimethoxy ‑ 4 ‑ (β ‑ methoxyethylthio)phenethylamine (2C ‑ T ‑ 13) 0.5 0.5 67 2,5 ‑ Dimethoxy ‑ 4 ‑ methylamphetamine (STP, DOM) 0.75 2.0 68 2,5 ‑ Dimethoxy ‑ 4 ‑ methylphenethylamine (2C ‑ D) 0.5 0.5 69 2,5 ‑ Dimethoxy ‑ 4 ‑ nitrophenethylamine (2C ‑ N) 0.5 0.5 70 2,5 ‑ Dimethoxy ‑ 4 ‑ (n) ‑ propylphenethylamine (2C ‑ P) 0.5 0.5 71 2,5 ‑ Dimethoxy ‑ 4 ‑ n ‑ propylthiophenethylamine (2C ‑ T ‑ 7) 0.5 0.5 72 2 ‑ (2,5 ‑ dimethoxyphenyl) ‑ N ‑ [(2 ‑ methoxyphenyl)methyl] ethanamine (25 ‑ H ‑ NBOMe) 0.002 0.002 73 1 ‑ Dimethylamino ‑ 1,2 ‑ diphenylethane 5.0 5.0 74 1,1 ‑ Dimethylheptyl ‑ 11 ‑ hydroxytetrahydrocannabinol (HU ‑ 210) 5.0 2.0 75 Dimethylthiambutene 20.0 20.0 76 N,N ‑ Dimethyltryptamine 2.0 2.0 77 Dioxaphetyl butyrate 2.0 2.0 77A Dipentylone (N,N ‑ dimethylpentylone) 0.75 2.0 78 Diphenoxylate 2.0 2.0 79 Dipipanone 10.0 10.0 80 Drotebanol 2.0 2.0 81 Ecgonine 10.0 10.0 82 Ethchlorvynol 50.0 50.0 83 Ethinamate 50.0 50.0 83A Ethylene etonitazene 0.005 0.005 83B Ethyleneoxynitazene 0.005 0.005 84 Ethylmethylthiambutene 10.0 10.0 85 Ethylmorphine 2.0 2.0 85A Etodesnitazene (etazene) 0.005 0.005 86 Etonitazene 0.005 0.005 86A Etonitazepipne (N ‑ piperidinyl etonitazene) 0.005 0.005 86B Etonitazepyne (N ‑ pyrrolidino etonitazene) 0.005 0.005 87 Etorphine 5.0 5.0 88 Etoxeridine 5.0 5.0 89 Fentanyl 0.005 0.005 89A Flunitazene 0.005 0.005 89B 2 ‑ Fluorodeschloroketamine (2 ‑ FDCK) 1.0 3.0 90 4 ‑ Fluoro ‑ 2,5 ‑ dimethoxyphenethylamine (2C ‑ F) 0.5 0.5 91 4 ‑ (2 ‑ Fluoroethylthio) ‑ 2,5 ‑ dimethoxyphenethylamine (2C ‑ T ‑ 21) 0.5 0.5 92 1 ‑ (5 ‑ fluoropentyl) ‑ 3 ‑ (2 ‑ iodobenzyl)indole (AM ‑ 694) 5.0 2.0 92A Furanylfentanyl 0.005 0.005 93 Furethidine 1.0 1.0 94 Gammabutyrolactone (GBL) 1.0 2.0 95 Glutethimide 50.0 50.0 96 Harmaline 5.0 2.0 97 Harmine 5.0 2.0 98 Heroin (diacetylmorphine) 1.5 2.0 99 Hydrocodone 2.0 2.0 100 Hydromorphinol 2.0 2.0 101 Hydromorphone 2.0 2.0 102 Hydroxyamphetamine 2.0 2.0 103 4 ‑ Hydroxybutanoic acid (GHB) 1.0 2.0 104 2 ‑ [(1R,3S) ‑ 3 ‑ hydroxycyclohexyl] ‑ 5 ‑ (2 ‑ methyloctan ‑ 2 ‑ yl)phenol (CP 47,497) 5.0 2.0 105 2 ‑ [(1R,3S) ‑ 3 ‑ hydroxycyclohexyl] ‑ 5 ‑ (2 ‑ methylnonan ‑ 2 ‑ yl)phenol (CP 47,497 ‑ C8) 5.0 2.0 106 Hydroxypethidine 5.0 5.0 107 2 ‑ (4 ‑ iodo ‑ 2,5 ‑ dimethoxyphenyl) ‑ N ‑ [(2 ‑ methoxyphenyl) methyl]ethanamine (25 ‑ I ‑ NBOMe) 0.002 0.002 108 Isomethadone 2.0 2.0 109 4 ‑ Isopropoxy ‑ 2,5 ‑ dimethoxyphenethylamine (2C ‑ O ‑ 4) 0.5 0.5 109A Isotodesnitazene 0.005 0.005 109B Isotonitazene 0.005 0.005 110 Ketamine 1.0 3.0 111 Ketobemidone 2.0 2.0 112 Levomethorphan 2.0 2.0 113 Levophenacylmorphan 2.0 2.0 114 Levorphanol, but not including dextrorphan 1.0 1.0 115 Lysergamide 0.01 0.1 116 Lysergide (LSD) 0.002 0.002 117 Meprobamate 50.0 50.0 118 Mescaline 7.5 7.5 119 Metazocine 7.0 7.0 120 Methadone 2.0 2.0 121 Methamphetamine 0.75 2.0 122 Methaqualone 5.0 50.0 123 Methcathinone 0.75 2.0 124 Methorphan, but not including dextromethorphan 2.0 2.0 125 5 ‑ Methoxy ‑ alpha ‑ methyltryptamine (5 ‑ MeO ‑ AMT) 2.0 2.0 126 4 ‑ Methoxyamphetamine 0.75 2.0 127 5 ‑ Methoxy ‑ N,N ‑ diisopropyltryptamine (5 ‑ MeO ‑ DiPT) 2.0 2.0 128 4 ‑ Methoxymethamphetamine 0.75 2.0 129 2 ‑ (2 ‑ Methoxyphenyl) ‑ 1 ‑ (1 ‑ pentylindol ‑ 3 ‑ yl)ethanone (JWH ‑ 250) 5.0 2.0 130 4 ‑ Methylamphetamine 0.75 2.0 131 Methyldesorphine 2.0 2.0 132 Methyldihydromorphine 2.0 2.0 133 3,4 ‑ Methylenedioxyamphetamine (MDA) 0.75 0.5 134 3,4 ‑ Methylenedioxymethamphetamine (MDMA) 0.5 0.5 134A Methylenedioxynitazene (2 ‑ (2 ‑ (benzo[d] [1,3]dioxol ‑ 5 ‑ ylmethyl) ‑ 5 ‑ nitro ‑ 1H ‑ benzo [d]imidazol ‑ 1 ‑ yl) ‑ N,N ‑ diethylethan ‑ 1 ‑ amine) 0.005 0.005 135 3,4 ‑ Methylenedioxypyrovalerone (MDPV) 0.75 2.0 136 3 ‑ Methylfentanyl 0.005 0.005 137 4 ‑ Methylmethamphetamine 0.75 2.0 138 4 ‑ Methylmethcathinone (4 ‑ MMC) 0.75 2.0 139 Methylphenidate 2.0 2.0 140 1 ‑ Methyl ‑ 4 ‑ phenyl ‑ 4 ‑ propionoxypiperidine (MPPP) 2.0 2.0 141 4 ‑ Methylthio ‑ 2,5 ‑ dimethoxyphenethylamine (2C ‑ T) 0.5 0.5 142 4 ‑ Methylthioamphetamine (4 ‑ MTA) 0.75 2.0 143 4 ‑ Methylthiobutylamphetamine (4 ‑ MTBA) 0.75 2.0 144 4 ‑ Methylthiodimethamphetamine (4 ‑ MTDMA) 0.75 2.0 145 4 ‑ Methylthioethylamphetamine (4 ‑ MTEA) 0.75 2.0 146 3 ‑ Methylthiofentanyl 0.005 0.005 147 4 ‑ Methylthiomethamphetamine (4 ‑ MTMA) 0.75 2.0 148 4 ‑ Methylthiopropylamphetamine (4 ‑ MTPA) 0.75 2.0 149 Methyprylon 50.0 50.0 149A Metodesnitazene (metazene) 0.005 0.005 149B Metonitazene 0.005 0.005 150 Metopon 2.0 2.0 151 Monoacetylmorphines 2.0 2.0 152 Moramide 2.0 2.0 153 Morphan, but not including dextrorphan 2.0 2.0 154 Morpheridine 2.0 2.0 155 Morphine 1.5 2.0 156 Morphine ‑ N ‑ oxide 2.0 2.0 157 (1 ‑ (2 ‑ Morpholin ‑ 4 ‑ ylethyl)indol ‑ 3 ‑ yl) ‑ napthalen ‑ 1 ‑ ylmethanone (JWH ‑ 200) 5.0 2.0 158 Myrophine 20.0 20.0 159 Napthalen ‑ 1 ‑ yl ‑ (1 ‑ butylindol ‑ 3 ‑ yl)methanone (JWH ‑ 073) 5.0 2.0 160 Nicocodine 2.0 2.0 161 Nicodicodine 2.0 2.0 162 Nicomorphine 2.0 2.0 163 Noracymethadol 2.0 2.0 164 Norcodeine 2.0 2.0 165 Norlevorphanol 2.0 2.0 166 Normethadone 5.0 5.0 167 Normorphine 20.0 20.0 168 Norpipanone 10.0 10.0 169 Opium 20.0 20.0 170 Oripavine 2.0 2.0 171 Oxycodone 5.0 5.0 172 Oxymorphone 2.0 2.0 173 para ‑ Fluorofentanyl 0.005 0.005 174 Pentazocine 20.0 20.0 175 1 ‑ Pentyl ‑ 3 ‑ (1 ‑ napthoyl)indol (JWH ‑ 018) 5.0 2.0 176 1 ‑ Pentyl ‑ 3 ‑ (4 ‑ methyl ‑ 1 ‑ napthoyl)indole (JWH ‑ 122) 5.0 2.0 177 Pethidine 10.0 10.0 178 Phenadoxone 10.0 10.0 179 Phenampromide 10.0 10.0 180 Phenazocine 1.0 1.0 181 Phencyclidine 2.0 2.0 182 Phendimetrazine 5.0 5.0 183 Phenmetrazine 5.0 5.0 184 Phenomorphan 5.0 5.0 185 Phenoperidine 1.0 1.0 186 Phentermine 5.0 5.0 187 1 ‑ Phenylethyl ‑ 4 ‑ phenyl ‑ 4 ‑ acetoxypiperidine (PEPAP) 2.0 2.0 187A 3 ‑ Phenylpropanoylfentanyl 0.005 0.005 188 Pholcodine 5.0 5.0 189 Piminodine 10.0 10.0 190 Pipradrol 1.0 1.0 191 Piritramide 1.0 1.0 192 Proheptazine 1.0 1.0 193 Properidine 25.0 25.0 194 Propiram 10.0 10.0 194A Protonitazene 0.005 0.005 194B Protonitazepyne (N ‑ pyrrolidino protonitazene) 0.005 0.005 195 Psilocine 0.1 0.1 196 Psilocybine 0.1 0.1 197 Pyrovalerone 0.75 2.0 197A Secofentanyl 0.005 0.005 198 Tetrahydrocannabinols (THC) 5.0 2.0 199 Thebacon 2.0 2.0 200 Thebaine 2.0 2.0 201 Thiofentanyl 0.005 0.005 201A Thiofuranylfentanyl 0.005 0.005 202 Trimeperidine 10.0 10.0 203 2,3,4 ‑ Trimethoxyamphetamine 0.75 2.0 204 2,3,5 ‑ Trimethoxyamphetamine 0.75 2.0 205 2,3,6 ‑ Trimethoxyamphetamine 0.75 2.0 206 2,4,5 ‑ Trimethoxyamphetamine 0.75 2.0 207 2,4,6 ‑ Trimethoxyamphetamine 0.75 2.0 208 3,4,5 ‑ Trimethoxyamphetamine 0.75 2.0 209 2,4,5 ‑ Trimethoxyphenethylamine (2C ‑ O) 0.5 0.5 Restricted listing (2) The following table lists: (a) substances that are taken to be border controlled drugs only in relation to the following: (i) an offence against subsection 307.1(1), 307.2(1), 307.3(1) or 307.4(1) of the Code, if the offence relates to importing a substance; (ii) an offence against subsection 307.5(1), 307.6(1), 307.7(1), 307.8(1), 307.9(1) or 307.10(1) of the Code; (iii) an offence against subsection 309.12(1) or 309.13(1) of the Code, if the offence relates to procuring an individual to import a substance; and (b) the quantities of those drugs that are commercial quantities and marketable quantities. Note: For a drug analogue of a substance listed in the table, see paragraph 301.4(1)(b) and subsection 301.4(3) of the Code. Border controlled drugs and quantities—restricted listing Item Border controlled drug Commercial quantity (kilograms) Marketable quantity (grams) 1 1,4 ‑ Butanediol (1,4 ‑ BD) 1.0 2.0 Endnotes Endnote 1—About the endnotes The endnotes provide information about this compilation and the compiled law. The following endnotes are included in every compilation: Endnote 1—About the endnotes Endnote 2—Abbreviation key Endnote 3—Legislation history Endnote 4—Amendment history Abbreviation key—Endnote 2 The abbreviation key sets out abbreviations that may be used in the endnotes. Legislation history and amendment history—Endnotes 3 and 4 Amending laws are annotated in the legislation history and amendment history. The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation. The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law. Editorial changes The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date. If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel. Misdescribed amendments A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003 . If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history. Endnote 2—Abbreviation key ad = added or inserted orig = original am = amended p = page(s) amdt = amendment para = paragraph(s)/subparagraph(s) C[x] = Compilation No. x /sub ‑ subparagraph(s) ch = Chapter(s) pres = present cl = clause(s) prev = previous cont. = continued (prev…) = previously def = definition(s) pt = Part(s) Dict = Dictionary r = regulation(s)/Court rule(s) disallowed = disallowed by Parliament reloc = relocated div = Division(s) renum = renumbered ed = editorial change rep = repealed exp = expires/expired or ceases/ceased to have rs = repealed and substituted effect s = section(s)/subsection(s) gaz = gazette /rule(s)/subrule(s)/order(s)/suborder(s) LA = Legislation Act 2003 sch = Schedule(s) LIA = Legislative Instruments Act 2003 SLI = Select Legislative Instrument (md) = misdescribed amendment can be given SR = Statutory Rules effect sub ch = Sub ‑ Chapter(s) (md not incorp) = misdescribed amendment sub div = Subdivision(s) cannot be given effect sub pt = Subpart(s) mod = modified/modification underlining = whole or part not No. = Number(s) commenced or to be commenced Ord = Ordinance Endnote 3—Legislation history Name Registration Commencement Application, saving and transitional provisions Criminal Code Regulations 2019 8 Apr 2019 (F2019L00561) 9 Apr 2019 (s 2(1) item 1) Criminal Code and Customs Legislation Amendment (Precursors and Drugs) Regulations 2020 10 Aug 2020 (F2020L01003) sch 1 (items 1 ‑ 12): 12 Aug 2020 (s 2(1) item 1) — Counter ‑ Terrorism Legislation Amendment (High Risk Terrorist Offenders) Regulations 2021 20 Dec 2021 (F2021L01842) sch 1 (item 1): 21 Dec 2021 (s 2(1) item 1) — Crimes Legislation Amendment (Community Safety Orders and Other Measures) Regulations 2023 7 Dec 2023 (F2023L01628) sch 1 (items 1 ‑ 5): 8 Dec 2023 (s 2(1) item 1) — Criminal Code Amendment (Border Controlled Drugs and Precursors) Regulations 2024 29 Feb 2024 (F2024L00249) 1 Mar 2024 (s 2(1) item 1) sch 1 (item 10) Criminal Code Amendment (Controlled and Border Controlled Drugs and Precursors) Regulations 2025 24 Jan 2025 (F2025L00032) 1 Mar 2025 (s 2(1) item 1) — Counter Terrorism Legislation Amendment (State Sponsors of Terrorism) Regulations 2025 12 Dec 2025 (F2025L01544) sch 1 (item 4): 13 Dec 2025 (s 2(1) item 1) — Endnote 4—Amendment history Provision affected How affected Part 1 s 2 ..................... rep LA s 48D Part 2 Division 3 s 10 .................... am F2021L01842; F2023L01628; F2025L01544 Part 3 Division 1 s 13 .................... am F2020L01003; F2025L00032 s 14 .................... am F2024L00249 s 15 .................... am F2024L00249 s 16 .................... am F2020L01003; F2024L00249; F2025L00032 Division 4 Division 4 ................ ad F2023L01628 s 20A ................... ad F2023L01628 s 20B ................... ad F2023L01628 Schedule 1 c 1 ..................... am F2025L00032 Schedule 2 c 1 ..................... am F2024L00249; F2025L00032